Topical Timolol Administration Reduces the Incidence of Glaucomatous Damage in Ocular Hypertensive Individuals. A Randomized, Double-Masked, Long-Term Clinical Trial (1)
OBJECTIVESA randomized, double-masked, 5-year clinical trial was conducted to determine whether topical timolol therapy was more effective than placebo in delaying or preventing the onset of glaucomatous damage in moderate-risk ocular hypertensive subjects. METHODSOne eye was chosen randomly to rece...
Gespeichert in:
Veröffentlicht in: | Journal of glaucoma 1993, Vol.2 Suppl A (Supplement A), p.1-2 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!